Frazier Life Sciences IX L.P. 13D and 13G filings for Passage Bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-06-15 10:25 am Sale | 2023-06-13 | 13D | Passage Bio, Inc. PASG | Frazier Life Sciences IX L.P. | 2,543,698 4.700% | -1,213,217 (-32.29%) | Filing |
| 2022-08-15 11:29 am Sale | 2022-08-11 | 13D | Passage Bio, Inc. PASG | Frazier Life Sciences IX L.P. | 3,756,915 6.900% | -1,264,523 (-25.18%) | Filing |
| 2021-01-27 2:56 pm Purchase | 2021-01-26 | 13D | Passage Bio, Inc. PASG | Frazier Life Sciences IX L.P. | 5,021,438 9.500% | 12,219 (+0.24%) | Filing |
| 2020-03-09 5:16 pm Purchase | 2020-03-03 | 13D | Passage Bio, Inc. PASG | Frazier Life Sciences IX L.P. | 5,009,219 10.900% | 5,009,219 (New Position) | Filing |